Position in INSM
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$416,670
-$77,951 QoQ
Shares Held
3,908
+37.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#421
of 663 holders
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026B. Riley Wealth Advisors, Inc. holds $3,874,293 across 11 Biotechnology names. INSM ranks #3 (10.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,403 | $1,193,642 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
113,000 | $989,315 | |
| 3 | INSM |
INSMED Inc
This page
|
3,908 | $416,670 | |
| 4 | DNLI |
Denali Therapeutics Inc.
|
12,813 | $329,550 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
414 | $258,145 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
2,897 | $229,703 | |
| 7 | IOVA |
Iovance Biotherapeutics, Inc.
|
51,000 | $212,160 | |
| 8 | OMER |
Omeros Corp
|
11,369 | $108,119 |
All Filings in INSM
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $416,670 | 3,908 | Shares | Sole | 2026-07-14 | |
| 2025-12-31 | $494,621 | 2,842 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $401,067 | 2,785 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $291,252 | 2,894 | Shares | Sole | 2025-08-19 | |
| No filing history on record for this holder in this stock. | ||||||